These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20639027)

  • 21. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocturia: a non-specific but important symptom of urological disease.
    Schneider T; de la Rosette JJ; Michel MC
    Int J Urol; 2009 Mar; 16(3):249-56. PubMed ID: 19226359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary.
    Yokoyama O; Yamaguchi O; Kakizaki H; Itoh N; Yokota T; Okada H; Ishizuka O; Ozono S; Gotoh M; Sugiyama T; Seki N; Yoshida M; Yamada S
    J Urol; 2011 Jul; 186(1):170-4. PubMed ID: 21575976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural fill urodynamics and conventional cystometrogram in infants with neurogenic bladder.
    Jorgensen B; Olsen LH; Jorgensen TM
    J Urol; 2009 Apr; 181(4):1862-7; discussion 1867-8. PubMed ID: 19233391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocturia in older men.
    van Doorn B; Bosch JL
    Maturitas; 2012 Jan; 71(1):8-12. PubMed ID: 22079871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
    Lee SR; Hong CH; Choi YD; Kim JH
    J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturia in patients with overactive bladder.
    Espuña-Pons M; Blasco P; Pérez M; Rebollo P
    Arch Esp Urol; 2010 Jun; 63(5):363-72. PubMed ID: 20587841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling.
    Ballert KN; Nitti VW
    J Urol; 2010 Feb; 183(2):641-5. PubMed ID: 20018325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders.
    Mukerji G; Waters J; Chessell IP; Bountra C; Agarwal SK; Anand P
    BMC Urol; 2006 Dec; 6():31. PubMed ID: 17192176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urgency is an independent factor for sleep disturbance in men with obstructive sleep apnea.
    Tsujimura A; Takao T; Miyagawa Y; Yamamoto K; Fukuhara S; Nakayama J; Kiuchi H; Suganuma N; Nakamura T; Kumano-Go T; Sugita Y; Nonomura N; Okuyama A
    Urology; 2010 Oct; 76(4):967-70. PubMed ID: 20381845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation and treatment of nocturia: a consensus statement.
    Weiss JP; Blaivas JG; Bliwise DL; Dmochowski RR; Dubeau CE; Lowe FC; Petrou SP; Van Kerrebroeck PE; Rosen RC; Wein AJ
    BJU Int; 2011 Jul; 108(1):6-21. PubMed ID: 21676145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
    Kim SH; Kim TB; Kim SW; Oh SJ
    J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocturnal Urinary Disorders and Multiple Sclerosis: Clinical and Urodynamic Study of 309 Patients.
    Mauruc E; Guinet-Lacoste A; Falcou L; Manceau P; Verollet D; Le Breton F; Amarenco G
    J Urol; 2017 Feb; 197(2):432-437. PubMed ID: 27816615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturia in women.
    Robinson D
    Int J Clin Pract Suppl; 2007 Sep; (155):23-31. PubMed ID: 17727576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.
    Schulte-Baukloh H; Weiss C; Stolze T; Stürzebecher B; Knispel HH
    Urology; 2005 Jul; 66(1):82-7. PubMed ID: 15992872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia.
    Weiss JP; van Kerrebroeck PE; Klein BM; Nørgaard JP
    J Urol; 2011 Oct; 186(4):1358-63. PubMed ID: 21855948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of persistent detrusor overactivity after transvaginal sling procedures.
    Gamble TL; Botros SM; Beaumont JL; Goldberg RP; Miller JJ; Adeyanju O; Sand PK
    Am J Obstet Gynecol; 2008 Dec; 199(6):696.e1-7. PubMed ID: 18845297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.